Treatment of Metastatic Bone Pain Using Bone-Seeking Agents

With the arrival of new therapeutic tracers, nuclear medicine has a new arsenal to treat metastatic bone pain. This presentation aims to give the keys to define the place of nuclear medicine among other treatment modalities (external beam therapy, medical treatment, chemotherapy). Learning Objectives: Refresh knowledge on the pathophysiology of pain and present the opportunities […]

Free

Algorithms for Dementia Imaging

Future Health Lab Alfred-Adler-Straße 1, Vienna, Austria

The course will offer a comprehensive overview of basic, theoretical and practical evidence-based concepts needed for a deep and thoughtful understanding of the use of FDG (FDG) Brain PET, amyloid (Amy) PET and DaT SPECT in Neurological Disorders. A brief introduction will be given on the position that each imaging technique holds in the recent […]

€950

Bone Scan Beyond Oncological Disease

The webinar primarily focuses on the clinical value and implementation of early phase SPECT-CT in non-oncological settings, emphasizing its advantages over traditional planar imaging and late-phase bone scans. It highlights the diagnostic enhancement of early-phase imaging for inflammatory conditions, pain assessment, and soft-tissue evaluation. New treatment options for cardiac amyloidosis are increasing interest in early […]

Free

Artificial Intelligence in Nuclear Medicine – Current Status and Future Perspective

Future Health Lab Alfred-Adler-Straße 1, Vienna, Austria

Artificial intelligence with the development of deep learning has found numerous applications in the medical field over the past few years, including more specifically that of medical imaging. This includes most areas governing the medical imaging process from detector signal processing to image formation and subsequent image processing. The activity of deep learning spans from […]

Surgery in Neuroendocrine Neoplasms (NENs)

Neuroendocrine tumours (NETs) are a rare but clinically significant group of malignancies arising from neuroendocrine cells, often presenting in the gastrointestinal tract or lungs. While NETs account for a small fraction of overall cancer cases, their incidence is steadily rising. Radioguided surgery has emerged as a highly effective approach for treating NETs, particularly in cases […]

Free

Cardiac Amyloidosis Imaging: History, Status Quo and Outlook

Future Health Lab Alfred-Adler-Straße 1, Vienna, Austria

This course provides a comprehensive overview of the multimodality diagnosis of cardiac amyloidosis. Background information on amyloidosis in general is presented and typical disease manifestations are discussed. Furthermore, the significance of cardiac amyloidosis will be discussed in detail and possible therapeutic options will be explained. Imaging modalities will include a focus on echocardiography, cardiac MRI, […]

Theranostic Training: Practical and Methodological Concepts

This webinar aims to introduce the concept of theranostics and provide an overview of its potential. Participants will gain an understanding of how our technological competencies contribute to and enhance theranostic processes, and how we can leverage these strengths in practice. Please note that the webinar will be recorded, and the recording will be available […]

Free

Radioiodine-Refractory Thyroid Cancer – Is it Time to Change the Definition in the Light of Novel Redifferentiation Therapies?

This webinar explores the perspectives on radiorefractory thyroid cancer through two presentations. In the first talk the speaker challenges current diagnostic frameworks and proposes a new vision that better reflects the evolving understanding of refractory thyroid cancer. The second presentation offers a comprehensive review of emerging approaches to restore iodine avidity in radiorefractory thyroid cancer, […]

Free

Treatment of Metastatic Bone Pain Using Bone-Seeking Agents

Future Health Lab Alfred-Adler-Straße 1, Vienna, Austria

Internal radiotherapy with bone-seeking agents is effective in delivering high doses of radiation to widespread metastatic bone lesions and may limit the radiation absorbed dose to healthy tissue. Beta emitter have long been preferred agents for bone pain palliation. The approval of 223Ra and data showing a prolonged survival with alpha emitter are favored in […]